These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28147442)

  • 1. Emerging ocular biomarkers of Alzheimer disease.
    van Wijngaarden P; Hadoux X; Alwan M; Keel S; Dirani M
    Clin Exp Ophthalmol; 2017 Jan; 45(1):54-61. PubMed ID: 28147442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between Alzheimer disease and cataract].
    Liu SS; Zhu SQ
    Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):314-316. PubMed ID: 28412806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular Biomarkers of Alzheimer's Disease: The Role of Anterior Eye and Potential Future Directions.
    Dehghani C; Frost S; Jayasena R; Masters CL; Kanagasingam Y
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3554-3563. PubMed ID: 30025102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease.
    Tian T; Zhang B; Jia Y; Li Z
    Dis Markers; 2014; 2014():826503. PubMed ID: 24688166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the lens model provide a biomarker for Alzheimer's disease?
    Tian T; Zhang B; Jia Y; Li Z
    Brain Pathol; 2013 Nov; 23(6):696. PubMed ID: 24118485
    [No Abstract]   [Full Text] [Related]  

  • 6. Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers.
    Chang LY; Lowe J; Ardiles A; Lim J; Grey AC; Robertson K; Danesh-Meyer H; Palacios AG; Acosta ML
    Alzheimers Dement; 2014 Mar; 10(2):251-61. PubMed ID: 24011928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration.
    Romaus-Sanjurjo D; Regueiro U; López-López M; Vázquez-Vázquez L; Ouro A; Lema I; Sobrino T
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A test of lens opacity as an indicator of preclinical Alzheimer Disease.
    Bei L; Shui YB; Bai F; Nelson SK; Van Stavern GP; Beebe DC
    Exp Eye Res; 2015 Nov; 140():117-123. PubMed ID: 25773986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease.
    Singh AK; Verma S
    Indian J Ophthalmol; 2020 Apr; 68(4):555-561. PubMed ID: 32174567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease.
    Ong SS; Doraiswamy PM; Lad EM
    JAMA Neurol; 2018 Jun; 75(6):650-651. PubMed ID: 29710250
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin.
    Parthasarathy R; Chow KM; Derafshi Z; Fautsch MP; Hetling JR; Rodgers DW; Hersh LB; Pepperberg DR
    Exp Eye Res; 2015 Sep; 138():134-44. PubMed ID: 26142956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β as a biomarker for Alzheimer's disease: quantification methods in body fluids.
    Galozzi S; Marcus K; Barkovits K
    Expert Rev Proteomics; 2015 Aug; 12(4):343-54. PubMed ID: 26153725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer disease: Preclinical Alzheimer disease - the new frontier.
    Knopman DS
    Nat Rev Neurol; 2016 Nov; 12(11):620-621. PubMed ID: 27713487
    [No Abstract]   [Full Text] [Related]  

  • 14. Alzheimer disease: the landscape of ageing--insights from AD imaging markers.
    Villemagne VL; Masters CL
    Nat Rev Neurol; 2014 Dec; 10(12):678-9. PubMed ID: 25366111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies.
    Buccarello L; Sclip A; Sacchi M; Castaldo AM; Bertani I; ReCecconi A; Maestroni S; Zerbini G; Nucci P; Borsello T
    Oncotarget; 2017 Oct; 8(47):83038-83051. PubMed ID: 29137322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion Channels in the Eye: Involvement in Ocular Pathologies.
    Giblin JP; Comes N; Strauss O; Gasull X
    Adv Protein Chem Struct Biol; 2016; 104():157-231. PubMed ID: 27038375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of amyloid-beta in lenses of Alzheimer patients: a confocal Raman microspectroscopic study.
    Michael R; Otto C; Lenferink A; Gelpi E; Montenegro GA; Rosandić J; Tresserra F; Barraquer RI; Vrensen GF
    Exp Eye Res; 2014 Feb; 119():44-53. PubMed ID: 24333259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Choline in Ocular Diseases.
    Hwang JS; Shin YJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is amyloid-β harmful to the brain? Insights from human imaging studies.
    Jagust W
    Brain; 2016 Jan; 139(Pt 1):23-30. PubMed ID: 26614753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
    VanItallie TB
    Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.